national stem-cell therapy logo

Revolutionizing Parkinson’s Disease Treatment: TreeFrog Therapeutics’ Leap Forward

A man with Parkinson's sitting on a park bench

In the ever-evolving field of regenerative medicine, a significant milestone is on the horizon, courtesy of TreeFrog Therapeutics. At the 23rd Congress of the Japanese Society for Regenerative Medicine (JSRM) in Niigata, Japan, a presentation by Maxime Feyeux, the Chief Scientific Officer and Co-founder of TreeFrog, has sparked excitement and hope. TreeFrog Therapeutics, a frontrunner […]

Aspen Neuroscience Cofounder Dr. Andrés Bratt-Leal Receives 2023 Biocom California Life Science Catalyst Award

Aspen's Dr. Andres Bratt Leal

Dr. Andrés Bratt-Leal, co-founder and Senior Vice President of Research and Development at Aspen Neuroscience, has been honored with the prestigious 2023 Biocom California Life Science Catalyst Award. This accolade, presented by Biocom California, recognizes the most inspiring and driven young minds in the California life sciences industry who are making significant contributions to human […]

FDA Grants Fast Track Designation to ANPD001 for Parkinson’s Disease Treatment

Aspen Neuroscience Logo

Aspen Neuroscience, a clinical development-stage company, recently announced a significant milestone in the fight against Parkinson’s disease (PD). The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ANPD001, an autologous (personalized) investigational cell therapy designed to treat Parkinson’s disease by replacing lost dopamine neurons. This designation aims to accelerate the development […]

BlueRock’s Phase I Study with Bemdaneprocel in Parkinson’s Disease Patients Achieves Main Goal

BlueRock Therapeutics

BlueRock Therapeutics, in collaboration with Bayer AG, recently announced the successful results of their Phase I clinical trial for bemdaneprocel (BRT-DA01), an innovative cellular therapy derived from stem cells, aimed at treating Parkinson’s disease. The findings were presented at the International Congress of Parkinson’s Disease and Movement Disorders in Copenhagen, Denmark. Key Highlights: Dr. Claire […]

Rune Labs and Aspen Neuroscience Collaborate on Parkinson’s Disease Study

Rune Labs Logo

Rune Labs, a leading precision neurology software and data platform company, has joined forces with Aspen Neuroscience Inc., a prominent autologous cell therapy biotechnology firm. The collaboration aims to leverage Rune Labs’ StriveStudy clinical development platform, enabling Aspen to gather real-time, longitudinal patient data remotely. The primary objective of this partnership is to utilize the […]

Aspen’s Breakthrough FDA-Cleared Parkinson’s Cell Therapy Unveiled

Aspen Neuroscience Logo

Aspen Neuroscience has announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for ANPD001, an autologous cell therapy designed to treat Parkinson’s Disease (PD) by replacing lost dopamine neurons. The clearance enables Aspen to initiate a first-in-patient Phase 1/2a clinical trial for individuals with moderate to severe […]

Unlocking the Brain’s Secret Weapon: The Power of Neural Stem Cells!

illustration of a healthy and colorful human brain

The Therapeutic Potential of Neural Stem Cells Imagine a construction site. The workers there are like cells in our body, each with a specific job to do. But among them, there are a few who are like the site managers, capable of taking on any role as needed. These are the stem cells, the body’s […]

Stem Cells vs. Parkinson’s: The Battle of the Century

Older male with Parkinson's walking in the park

Welcome! We’re delighted to have you join us on this exploration into a topic that is at the forefront of medical research: the potential of stem cell treatments for Parkinson’s disease. You might be asking, “What exactly is Parkinson’s disease?” It’s a crucial question and one that we need to address before we delve deeper […]

Groundbreaking Trials Aim to Combat Parkinson’s with Patients’ Own Cells

female researcher studying stem cells in a lab

San Diego-based startup Aspen Neuroscience plans to test the potential of lab-cultured brain cells, derived from a person’s own cells, to reverse Parkinson’s disease symptoms in human trials later this year. The company aims to determine if these injected cells can develop into dopamine-producing neurons, alleviating the disease’s debilitating symptoms. Animal tests have shown promise […]